Codexis (CDXS) EBIT Margin (2010 - 2026)

Codexis' (CDXS) quarterly EBIT Margin came in at 52.75% in Q1 2026, up 21884.0% year-on-year from N/an in Q1 2025, and down 294.4% quarter-over-quarter from 27.13% in Q4 2025.

Codexis (CDXS) EBIT Margin (2010 - 2026) Analysis & Trends

Codexis' EBIT Margin history runs 17 years deep, the most recent figure standing at 52.75% for Q1 2026.

  • On a quarterly basis, EBIT Margin rose 21884.0% year-over-year to 52.75% in Q1 2026; TTM through Mar 2026 was 37.51%, a 9722.0% increase from a year earlier, with the FY2025 full-year figure at 59.3%, up 3931.0% from the prior year.
  • EBIT Margin retreated to 52.75% in Q1 2026 per CDXS's latest filing, from 27.13% in the prior quarter.
  • Across five years, EBIT Margin topped out at 27.13% in Q4 2025 and bottomed at 345.59% in Q3 2023.
  • The 5-year median for EBIT Margin is 69.63% (2024), against an average of 118.96%.
  • Across the five-year window, EBIT Margin sank 31473 bps in 2023 and surged 21884 bps in 2026, its largest moves.
  • Year by year, EBIT Margin stood at 66.92% in 2022, then surged by 108 bps to 5.62% in 2023, then plunged by 709 bps to 34.21% in 2024, then soared by 179 bps to 27.13% in 2025, then tumbled by 294 bps to 52.75% in 2026.
  • Per Business Quant, the three latest CDXS EBIT Margin figures stand at 52.75% (Q1 2026), 27.13% (Q4 2025), and 220.31% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -
4 BeOne Medicines 471.62 Bn 466.83 Bn 1.35 Bn 16.51%
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn 17.83%
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.75 Bn 50.57 Bn 1.41 Bn 31.68%
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 23.02%
10 Codexis 137.51 Mn 72.37 Mn 13.18 Mn -52.75%

Historic Data

Download Data
DateValue
Mar 31, 2026 -52.75%
Dec 31, 2025 27.13%
Sep 30, 2025 -220.31%
Jun 30, 2025 -83.91%
Mar 31, 2025 -271.59%
Dec 31, 2024 -34.21%
Sep 30, 2024 -129.02%
Jun 30, 2024 -284.90%
Mar 31, 2024 -69.63%
Dec 31, 2023 5.62%
Sep 30, 2023 -345.59%
Jun 30, 2023 -252.52%
Mar 31, 2023 -182.29%
Dec 31, 2022 -66.92%
Sep 30, 2022 -30.86%
Jun 30, 2022 -6.79%
Mar 31, 2022 -23.73%
Dec 31, 2021 -42.39%
Sep 30, 2021 3.62%
Jun 30, 2021 -17.62%